Lemaitre Vascular (LMAT) Current Deferred Revenue (2018 - 2019)
Lemaitre Vascular's (LMAT) quarterly Current Deferred Revenue came in at $188000.0 in Q2 2019, down 80.23% year-on-year from $951000.0 in Q2 2018, and down 48.91% on a QoQ basis from $368000.0 in Q1 2019.
Lemaitre Vascular (LMAT) Current Deferred Revenue (2018 - 2019) Analysis & Trends
Lemaitre Vascular (LMAT) has 2 years of Current Deferred Revenue data on file, last reported at $188000.0 in Q2 2019.
- On a quarterly basis, Current Deferred Revenue fell 80.23% year-over-year to $188000.0 in Q2 2019; TTM through Jun 2019 was $188000.0, a 80.23% decrease from a year earlier, with the FY2018 full-year figure at $552000.0, changed N/A from the prior year.
- Current Deferred Revenue for Q2 2019 stood at $188000.0, down from $368000.0 in the prior quarter.
- Over the last five years, Current Deferred Revenue for LMAT reached as high as $951000.0 in Q2 2018 and fell as low as $188000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Lemaitre Vascular | 2.22 Bn | 1.86 Bn | 48.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 188,000.00 |
| Mar 31, 2019 | 368,000.00 |
| Dec 31, 2018 | 552,000.00 |
| Sep 30, 2018 | 752,000.00 |
| Jun 30, 2018 | 951,000.00 |